OBJECTIVES: To estimate the size of organic chemical space and its sub-regions, i.e. drug-like chemical space and known drug space (KDS). METHODS: Analysis of the growth of organic compounds as a function of their carbon atoms based on a power function (f(x)=A×B, C=x) and an exponential function (f(x)=AeBx). Also, the statistical distribution of KDS and drug-like chemical space (drugs with good oral-bioavailability) based on their carbon atom count was used to deduce their size. KEY FINDINGS: The power function (f(x)=A×B, C=x) gives a superior fit to the growth of organic compounds leading to an estimate of 3.4×109 populating chemical space. KDS is predicted to be 2.0×106 molecules and drug-like chemical space is calculated to be 1.1×106 compounds. CONCLUSIONS: The values here are much smaller than previously reported. However, the numbers are large but not astronomical. A clear rationale on how we reach these numbers is given, which hopefully will lead to more refined predictions.
No takes yet. Share an insight, caveat, or question.
Drew et al. (2011) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: